Keywords: novartis, certican, gets, swiss, approval, drugs, major

Novartis' Certican gets Swiss approval

Article | 30 May 2005

Print This

Swiss drugs major Novartis' Certican (everolimus) has recently been approved by Swissmedic for the prophylaxis of organ rejection in heart ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in